Overview
Quantum Innovations creates technologies for cardiac surgery, cardiology and respiratory medicine. Its products include the Heart Sense probe, designed to increase safety during cardiac surgery, and Heart Guard, a system for continuous measurement of cardiac metabolism; the devices aim to improve the safety of invasive procedures in cardiac surgery centers.
Financials
Revenue history (in k)
Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Bank accounts
Registered as a VAT taxpayer on 2017-08-10. Active
04 1090 1883 0000 0001 3409 0096
Debt
No entries in the National Debtors Register (KRZ). No proceedings in KRZ
Public aid
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Jan 22, 2019 | De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier) | $8,008$8,008 | Fundacja Innowacyjna Polska | |
| Jan 14, 2019 | De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier) | $2,883$2,883 | BTM Innovations sp. z o.o. | |
| Jun 7, 2018 | De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier) | $5,787$5,787 | BTM Innovations sp. z o.o. |
Tenders
No recorded participation in tenders.
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
 BDO | BDO register entry | Active |
Authorized Representatives
Manner of representation
Declarations of will on behalf of the company require the joint action of two members of the management board or one member of the management board and a commercial proxy. If a member of the management board representing the investor is appointed, declarations of will on behalf of the company require the joint action of the member of the management board–the Finance Director–with another member of the management board or a commercial proxy.
Supervisory board
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Przemysław Robert Furdal (38) | 64 | $864.40 | 22.5352% |
| 64 | $864.40 | 22.5352% | |
Grzegorz Łukasz Suwalski (47) | 78 | $1,053.48 | 27.4648% |
Vinci S.A. Iq Alternatywna Spółka Inwestycyjna Spółka Komandytowo- Akcyjna | 78 | $1,053.48 | 27.4648% |
Beneficial owners
| Person | Rights | |
|---|---|---|
Przemysław Robert Furdal (38)  | Shareholder of a limited liability company, 3200.0 PLN | |
Pawlos Theodoros Mandzios (39) | Other natural person. | |
Andrzej Michał Morawiec (67) | Other natural person. | |
Grzegorz Łukasz Suwalski (47) | Shareholder of a limited liability company, 3900.0 PLN |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Saventic Healthsp. z o.o. | $1,089,246.05 | saventic.com | ||
| MedisensonicS.A. | $362,572.63 | medisensonic.com | ||
| Oasis DiagnosticsS.A. | $282,613.94 | oasis-diagnostics.com | ||
| JAS Analyticssp. z o.o. | $245,699.54 | jasanalytics.eu | ||
| IntelliseqS.A. | $156,552.76 | intelliseq.pl | ||
| SatroecgS.A. | $117,301.57 | satroecg.pl | ||
| Advanced Diagnostic Equipmentsp. z o.o. | $43,171.56 | adediabetics.pl | ||
| SimplicardiacS.A. | $28,951.71 | simplicardiac.com | ||
| Medaisp. z o.o. | $22,311.83 | medai.pl | ||
| Braintechsp. z o.o. | $20,965.65 | braintech.pl |
Change history
| Date | Event | |
|---|---|---|
| 2025-11-13 | Address change (Ul. Młynarska 8/12, 01-194, Warszawa → Plac Bankowy 2, 00-095, Warszawa) | |
| 2024-10-01 | Share capital change (11,200.00 PLN → 14,200.00 PLN) | |
| 2024-08-21 | Address change (Ul. Sarmacka 11/114, 02-972, Warszawa → Ul. Młynarska 8/12, 01-194, Warszawa) | |
| 2024-06-25 | Share capital change (5,000.00 PLN → 11,200.00 PLN) | |
| 2021-06-25 | Address change (Ul. Józefa I Jana Rostafińskich 4, 02-593, Warszawa → Ul. Sarmacka 11/114, 02-972, Warszawa) |
FAQ
Last updated: 2026-06-24